After announcing a phase 3 launch based on positive midstage results, iTeos and GSK are finally sharing the highlights from ...

The split is no surprise: it has been public knowledge since the end of 2018 that GSK is going to spin off its consumer health business into a joint venture with Pfizer, but this is the first time ...

GlaxoSmithKline’s chairman, Philip Hampton, may be considering splitting the company amid pressure from top investors to separate the company into consumer, pharma and vaccines divisions.

TÜBINGEN, GERMANY and BOSTON, MA - GlaxoSmithKline (NYSE ... The Phase 2 study included 500 participants, split into two age groups, and tested various dose levels against a licensed comparator ...

Close to two thirds of British businesses think Labour’s reforms to workers’ rights will make the country a less attractive ...

Climate Asset Management has raised more than $1 billion to invest in natural capital projects such as regenerative agriculture, its chief executive told Reuters.

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

Modest, MD, of the Charité University of Medicine in Berlin, said that in looking at the PFS and OS curves, "what I like especially about these curves is that they split early ... Pierre Fabre, GSK, ...